Yuxa 35 Tablet contains a combination of Cyproterone acetate (2 mg) and Ethinyl Estradiol (0.035 mg), used primarily as an oral contraceptive and for the treatment of androgen-dependent conditions in females. Cyproterone acetate is an anti-androgen that inhibits the effects of male hormones, while Ethinyl Estradiol is a synthetic estrogen that helps regulate the menstrual cycle and provides contraceptive efficacy. Yuxa 35 is indicated for the prevention of pregnancy and management of conditions such as acne, hirsutism, and seborrhea associated with hyperandrogenism. The tablet works by suppressing ovulation, altering the cervical mucus to prevent sperm penetration, and modifying the endometrial lining to inhibit implantation. It should be taken orally once daily, preferably at the same time each day, following the prescribed regimen. Contraindications include a history of thromboembolic disorders, hormone-sensitive malignancies, liver disease, and known hypersensitivity to any components. Caution is advised in patients with cardiovascular risk factors, hypertension, or migraines. Common side effects may include nausea, headache, breast tenderness, and mood changes. Patients should consult healthcare providers before initiating therapy to ensure suitability and discuss potential interactions with other medications. Regular monitoring is recommended during prolonged use.